Pulse Angels is a UK angel syndicate focused on healthtech and medtech startups at pre-seed and seed stage. We help investors access high-quality opportunities with clearer diligence, stronger filtering, and a more structured investment process.
What you get
Curated Deal Flow
We review a large number of startups and share only a small number of opportunities that meet our bar for quality.
Rigorous due diligence
We assess market potential, commercial viability, team quality, and healthcare relevance before presenting opportunities.
Structured investing
We make it easier to invest through a more organised process, with clearer materials and better visibility.
Tax-efficient opportunities
Many deals are expected to qualify for SEIS or EIS, helping eligible UK investors invest more efficiently.
A stronger investor network
Join a community of operators, founders, clinicians, and experienced investors with relevant sector insight.
Who this is for
Pulse Angels is designed for investors who want:
- exposure to HealthTech and MedTech startups
- a more disciplined alternative to solo investing
- access to filtered early-stage opportunities
- to combine returns with meaningful impact
Our investment focus
We focus on pre-seed and seed startups :
- in digital health, medtech, diagnostics
- based primarily in the UK
- looking for investments between £50K and £500K
Request our investor pack to learn how Pulse Angels works, what we invest in, and how opportunities are shared.
Why invest in Healthtech & Medtech?
High Growth Potential
HealthTech is rapidly expanding, with UK investments rising from £420M in 2016 to £2.9B in 2022.
Government Support
Favourable policies and NHS initiatives create a strong environment for HealthTech innovation.
Positive Impact
HealthTech improves patient outcomes, expands access to care, and empowers individuals to manage their health.
Strong ROI
Innovations like AI diagnostics and telemedicine, make it ideal for both financial and impact-driven investors.
